WEIGHT LOSS MEDICATIONS
Wegovy and Mounjaro (aka Zepbound) are two of the most well-known weight loss medications offered today. Both are intended for patients with excess weight and obesity who have a BMI of 30 or higher or a BMI of 27 or higher with an additional obesity-related health problem. Both medications are intended to supplement a habit of increased physical activity as well as a reduced calorie diet; medication alone isn’t likely to have the intended outcome of weight loss.
About Wegovy
Wegovy is a once-weekly injection of semaglutide, which is a medication that boosts levels of glucagon-like-peptide (GLP-1) in the body. GLP-1 is a key regulator of weight and blood sugar. It helps to suppress appetite through the brain, and it slows stomach emptying to increase the sensation of fullness.
Losing weight with Wegovy requires a regular physical fitness regimen, dietary support, and healthy eating habits. The program begins with an initial medication consultation to review your medical history, discuss your weight loss goals, and determine if Wegovy is an appropriate treatment for you, along with an initial nutrition consultation.
About Mounjaro*
Mounjaro builds on the work of semaglutide; like semaglutide, it targets the GLP-1 receptor to boost GLP levels. But it also targets a second receptor, GIP (glucose dependent insulinotropic polypeptide). GIP is another hormone released into the digestive tract after we eat, and it appears to regulate weight through receptors in the brain and fat cells. More importantly, GLP-1 and GIP are synergistic and enhance each other’s effects.
Losing weight with Mounjaro requires a regular physical fitness regimen, dietary support, and healthy eating habits. The program begins with an initial medication consultation to review your medical history, discuss your weight loss goals, and determine if Mounjaro is an appropriate treatment for you, along with an initial nutrition consultation.
*Mounjaro (tirzepatide) is currently FDA approved for the treatment of type 2 diabetes in adults. Zepbound (tirzepatide) is FDA approved for the treatment of obesity.
